A hospital-wide Antimicrobial Stewardship Program optimizes antimicrobial use with the intention of stabilizing antimicrobial resistance, improving patient safety, and decreasing antimicrobial costs.
Research in the Division of Infectious Diseases on antimicrobial resistance and pathogenesis centers on both Gram-positive and Gram-negative organisms.
The goals of the Columbia Research Unit (CRU) are to set the standards of care for people living with HIV and help speed development of a vaccine to prevent HIV infection.
The Department of Infection Prevention & Control (IP&C) at NewYork-Presbyterian Hospital (NYP) works closely with the Division of Infectious Diseases in infection prevention and hospital epidemiology.
Malaria Drug Resistance, Pathogenesis, and Drug Discovery
Research in the division on malaria focuses on mechanisms of P. falciparum multidrug resistance and research into new antimalarials and elucidation of their modes of action.
Research focuses on the contribution of discrete microbial genetic traits to pathogenesis, drug resistance, and transmission of single bacterial species as well as of microbial communities.
